Acceleron, Stemline price upsized follow-ons

By Paul Bonanos | Jan 18, 2019 | 8:41 PM GMT

Acceleron Pharma Inc. (NASDAQ:XLRN) and Stemline Therapeutics Inc. (NASDAQ:STML) have each priced upsized follow-ons, as one company prepares for key regulatory submissions and the other conducts its first product launch.

Acceleron said Jan. 16 that it raised $230

Read the full 378 word article

How to gain access

Continue reading with a
two-week free trial.